Foresite Capital Opportunity Management V’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Foresite Capital Opportunity Management V’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$9.67M	Hold	5,227,307	–	–	29.04%	1
2022 Q2	$16M	Hold	5,227,307	–	–	40.44%	1
2022 Q1	$37.7M	Hold	5,227,307	–	–	52.85%	1
2021 Q4	$85.6M	Buy	+5,227,307	New	+$60.8M	57.37%	1

Other funds holding PRDS

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return